alomone labs cat b 250 Search Results


93
Alomone Labs recombinant human bdnf protein rhbdnf
Western blot analysis of the <t>BDNF</t> ( A , B ), trkB ( C , D ), and the PSA-NCAM ( E , F ), in the prefrontal (prelimbic/infralimbic) cortex of the RHA and the RLA rats, either untreated controls (CTRL) or treated with neonatal handling (NH). The values represent the densitometric analysis of the BDNF/GAPDH ( B ), trkB/GAPDH ( D ), and the PSA-NCAM/GAPDH ( F ) band grey optical density (O.D.) ratios. The bars denote the mean ± S.E.M. of 9–10 rats, in each experimental group. ***: p < 0.001 (post hoc Duncan’s multiple range test).
Recombinant Human Bdnf Protein Rhbdnf, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human bdnf protein rhbdnf/product/Alomone Labs
Average 93 stars, based on 1 article reviews
recombinant human bdnf protein rhbdnf - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

94
Bio-Techne corporation k 252a
Western blot analysis of the <t>BDNF</t> ( A , B ), trkB ( C , D ), and the PSA-NCAM ( E , F ), in the prefrontal (prelimbic/infralimbic) cortex of the RHA and the RLA rats, either untreated controls (CTRL) or treated with neonatal handling (NH). The values represent the densitometric analysis of the BDNF/GAPDH ( B ), trkB/GAPDH ( D ), and the PSA-NCAM/GAPDH ( F ) band grey optical density (O.D.) ratios. The bars denote the mean ± S.E.M. of 9–10 rats, in each experimental group. ***: p < 0.001 (post hoc Duncan’s multiple range test).
K 252a, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/k 252a/product/Bio-Techne corporation
Average 94 stars, based on 1 article reviews
k 252a - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

94
Alomone Labs biotinylated bdnf
(A) DIV 7 compartmentalized mouse cortical neurons were retrograde labeled with Ctb555 (red) overnight. At DIV 8, the cell body compartment was treated with TrkB-Fc, and the AC was treated with DyLight 488-conjugated streptavidin alone (Control) or with <t>biotinylated</t> <t>BDNF</t> coupled to DyLight 488-conjugated streptavidin (f-BDNF, 150 ng/mL) for 6 hours in the absence (BDNF, green) or presence of 5 μM U-73122 (BDNF + U-173122) or 20 μM BAPTA, AM (BDNF + BAPTA). Then, the cells were fixed, mounted in Mowiol containing Hoechst (blue) and prepared for visualization. The circles in the BDNF panel indicate the smallest BDNF endosome considered for the analysis shown in B. Scale bar, 5 μm (B) Quantification of BDNF-positive vesicles in cell bodies of neurons containing Ctb555. Only vesicles larger than 20*10 -2 μm 2 as shown in the BDNF treatment group by the circles in panel A were considered for the analysis. Forty-five neurons from three independent compartmentalized cultures were considered. Statistical analysis was performed by one-way ANOVA followed by the Bonferroni correction for multiple comparisons. **** P<0.0001. (C) Left panels, representative images of DyLight 488-conjugated streptavidin (green) associated fluorescence. White lines are selecting the region of the microgroove label with Ctb555 (red) shown in the right panels. White arrows indicate DyLight 488-conjugated streptavidin positive vesicles (control) or f-BDNF positive vesicles in the lower panels. Right panels, Representative images of axons (labeled with Ctb555, red) in microgrooves of neurons treated as described in A. Scale bar, 5 μm. (D) Quantification of BDNF-positive vesicles in microgrooves of axons containing Ctb555. Forty-five microgrooves from three independent compartmentalized cultures were considered for the analysis. Statistical analysis was performed by one-way ANOVA followed by the Bonferroni correction for multiple comparisons. **** P<0.0001.
Biotinylated Bdnf, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biotinylated bdnf/product/Alomone Labs
Average 94 stars, based on 1 article reviews
biotinylated bdnf - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

92
Alomone Labs recombinant human probdnf protein
(A) DIV 7 compartmentalized mouse cortical neurons were retrograde labeled with Ctb555 (red) overnight. At DIV 8, the cell body compartment was treated with TrkB-Fc, and the AC was treated with DyLight 488-conjugated streptavidin alone (Control) or with <t>biotinylated</t> <t>BDNF</t> coupled to DyLight 488-conjugated streptavidin (f-BDNF, 150 ng/mL) for 6 hours in the absence (BDNF, green) or presence of 5 μM U-73122 (BDNF + U-173122) or 20 μM BAPTA, AM (BDNF + BAPTA). Then, the cells were fixed, mounted in Mowiol containing Hoechst (blue) and prepared for visualization. The circles in the BDNF panel indicate the smallest BDNF endosome considered for the analysis shown in B. Scale bar, 5 μm (B) Quantification of BDNF-positive vesicles in cell bodies of neurons containing Ctb555. Only vesicles larger than 20*10 -2 μm 2 as shown in the BDNF treatment group by the circles in panel A were considered for the analysis. Forty-five neurons from three independent compartmentalized cultures were considered. Statistical analysis was performed by one-way ANOVA followed by the Bonferroni correction for multiple comparisons. **** P<0.0001. (C) Left panels, representative images of DyLight 488-conjugated streptavidin (green) associated fluorescence. White lines are selecting the region of the microgroove label with Ctb555 (red) shown in the right panels. White arrows indicate DyLight 488-conjugated streptavidin positive vesicles (control) or f-BDNF positive vesicles in the lower panels. Right panels, Representative images of axons (labeled with Ctb555, red) in microgrooves of neurons treated as described in A. Scale bar, 5 μm. (D) Quantification of BDNF-positive vesicles in microgrooves of axons containing Ctb555. Forty-five microgrooves from three independent compartmentalized cultures were considered for the analysis. Statistical analysis was performed by one-way ANOVA followed by the Bonferroni correction for multiple comparisons. **** P<0.0001.
Recombinant Human Probdnf Protein, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human probdnf protein/product/Alomone Labs
Average 92 stars, based on 1 article reviews
recombinant human probdnf protein - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

95
Alomone Labs recombinant human gdnf protein
(A) DIV 7 compartmentalized mouse cortical neurons were retrograde labeled with Ctb555 (red) overnight. At DIV 8, the cell body compartment was treated with TrkB-Fc, and the AC was treated with DyLight 488-conjugated streptavidin alone (Control) or with <t>biotinylated</t> <t>BDNF</t> coupled to DyLight 488-conjugated streptavidin (f-BDNF, 150 ng/mL) for 6 hours in the absence (BDNF, green) or presence of 5 μM U-73122 (BDNF + U-173122) or 20 μM BAPTA, AM (BDNF + BAPTA). Then, the cells were fixed, mounted in Mowiol containing Hoechst (blue) and prepared for visualization. The circles in the BDNF panel indicate the smallest BDNF endosome considered for the analysis shown in B. Scale bar, 5 μm (B) Quantification of BDNF-positive vesicles in cell bodies of neurons containing Ctb555. Only vesicles larger than 20*10 -2 μm 2 as shown in the BDNF treatment group by the circles in panel A were considered for the analysis. Forty-five neurons from three independent compartmentalized cultures were considered. Statistical analysis was performed by one-way ANOVA followed by the Bonferroni correction for multiple comparisons. **** P<0.0001. (C) Left panels, representative images of DyLight 488-conjugated streptavidin (green) associated fluorescence. White lines are selecting the region of the microgroove label with Ctb555 (red) shown in the right panels. White arrows indicate DyLight 488-conjugated streptavidin positive vesicles (control) or f-BDNF positive vesicles in the lower panels. Right panels, Representative images of axons (labeled with Ctb555, red) in microgrooves of neurons treated as described in A. Scale bar, 5 μm. (D) Quantification of BDNF-positive vesicles in microgrooves of axons containing Ctb555. Forty-five microgrooves from three independent compartmentalized cultures were considered for the analysis. Statistical analysis was performed by one-way ANOVA followed by the Bonferroni correction for multiple comparisons. **** P<0.0001.
Recombinant Human Gdnf Protein, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human gdnf protein/product/Alomone Labs
Average 95 stars, based on 1 article reviews
recombinant human gdnf protein - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

94
Alomone Labs neurotrophin 3/nt-3 blocking peptide
(A) DIV 7 compartmentalized mouse cortical neurons were retrograde labeled with Ctb555 (red) overnight. At DIV 8, the cell body compartment was treated with TrkB-Fc, and the AC was treated with DyLight 488-conjugated streptavidin alone (Control) or with <t>biotinylated</t> <t>BDNF</t> coupled to DyLight 488-conjugated streptavidin (f-BDNF, 150 ng/mL) for 6 hours in the absence (BDNF, green) or presence of 5 μM U-73122 (BDNF + U-173122) or 20 μM BAPTA, AM (BDNF + BAPTA). Then, the cells were fixed, mounted in Mowiol containing Hoechst (blue) and prepared for visualization. The circles in the BDNF panel indicate the smallest BDNF endosome considered for the analysis shown in B. Scale bar, 5 μm (B) Quantification of BDNF-positive vesicles in cell bodies of neurons containing Ctb555. Only vesicles larger than 20*10 -2 μm 2 as shown in the BDNF treatment group by the circles in panel A were considered for the analysis. Forty-five neurons from three independent compartmentalized cultures were considered. Statistical analysis was performed by one-way ANOVA followed by the Bonferroni correction for multiple comparisons. **** P<0.0001. (C) Left panels, representative images of DyLight 488-conjugated streptavidin (green) associated fluorescence. White lines are selecting the region of the microgroove label with Ctb555 (red) shown in the right panels. White arrows indicate DyLight 488-conjugated streptavidin positive vesicles (control) or f-BDNF positive vesicles in the lower panels. Right panels, Representative images of axons (labeled with Ctb555, red) in microgrooves of neurons treated as described in A. Scale bar, 5 μm. (D) Quantification of BDNF-positive vesicles in microgrooves of axons containing Ctb555. Forty-five microgrooves from three independent compartmentalized cultures were considered for the analysis. Statistical analysis was performed by one-way ANOVA followed by the Bonferroni correction for multiple comparisons. **** P<0.0001.
Neurotrophin 3/Nt 3 Blocking Peptide, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/neurotrophin 3/nt-3 blocking peptide/product/Alomone Labs
Average 94 stars, based on 1 article reviews
neurotrophin 3/nt-3 blocking peptide - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

93
Alomone Labs bdnf exogenous incubations
<t>BDNF/TrkB</t> signaling pathway modulates Munc18-1 phosphorylation under muscle contraction conditions. Representative Western blot bands and quantification show that <t>both</t> <t>exogenous</t> BDNF and 47/TrkB significantly decrease pMunc18-1 levels after stimulation resulting in contraction. Moreover, exogenous BDNF decreases Munc18-1 levels under these conditions. Data are mean percentage ± SEM, * p < 0.05 ( n = 5).
Bdnf Exogenous Incubations, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bdnf exogenous incubations/product/Alomone Labs
Average 93 stars, based on 1 article reviews
bdnf exogenous incubations - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Millipore puromycin dihydrochloride
<t>BDNF/TrkB</t> signaling pathway modulates Munc18-1 phosphorylation under muscle contraction conditions. Representative Western blot bands and quantification show that <t>both</t> <t>exogenous</t> BDNF and 47/TrkB significantly decrease pMunc18-1 levels after stimulation resulting in contraction. Moreover, exogenous BDNF decreases Munc18-1 levels under these conditions. Data are mean percentage ± SEM, * p < 0.05 ( n = 5).
Puromycin Dihydrochloride, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/puromycin dihydrochloride/product/Millipore
Average 90 stars, based on 1 article reviews
puromycin dihydrochloride - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

94
Alomone Labs recombinant human beta-ngf protein
<t>BDNF/TrkB</t> signaling pathway modulates Munc18-1 phosphorylation under muscle contraction conditions. Representative Western blot bands and quantification show that <t>both</t> <t>exogenous</t> BDNF and 47/TrkB significantly decrease pMunc18-1 levels after stimulation resulting in contraction. Moreover, exogenous BDNF decreases Munc18-1 levels under these conditions. Data are mean percentage ± SEM, * p < 0.05 ( n = 5).
Recombinant Human Beta Ngf Protein, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human beta-ngf protein/product/Alomone Labs
Average 94 stars, based on 1 article reviews
recombinant human beta-ngf protein - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

94
Bio-Techne corporation recombinant rat beta-ngf protein
<t>BDNF/TrkB</t> signaling pathway modulates Munc18-1 phosphorylation under muscle contraction conditions. Representative Western blot bands and quantification show that <t>both</t> <t>exogenous</t> BDNF and 47/TrkB significantly decrease pMunc18-1 levels after stimulation resulting in contraction. Moreover, exogenous BDNF decreases Munc18-1 levels under these conditions. Data are mean percentage ± SEM, * p < 0.05 ( n = 5).
Recombinant Rat Beta Ngf Protein, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant rat beta-ngf protein/product/Bio-Techne corporation
Average 94 stars, based on 1 article reviews
recombinant rat beta-ngf protein - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

96
InvivoGen lps-eb ultrapure
<t>BDNF/TrkB</t> signaling pathway modulates Munc18-1 phosphorylation under muscle contraction conditions. Representative Western blot bands and quantification show that <t>both</t> <t>exogenous</t> BDNF and 47/TrkB significantly decrease pMunc18-1 levels after stimulation resulting in contraction. Moreover, exogenous BDNF decreases Munc18-1 levels under these conditions. Data are mean percentage ± SEM, * p < 0.05 ( n = 5).
Lps Eb Ultrapure, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lps-eb ultrapure/product/InvivoGen
Average 96 stars, based on 1 article reviews
lps-eb ultrapure - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

93
Alomone Labs bdnf treatment
( A ) TrkB activation by <t>BDNF</t> is decreased by increased levels of TrkB.T1. HEK293 cells stably expressing TrkB.FL were transfected with increasing amounts of a TrkB.T1 expressing plasmid (0.3 µg, 0.5 µg and 1 µg) before <t>BDNF</t> <t>treatment</t> (5 ng/ml for 5 min). Immunoblots were probed with antibodies against TrkB extracellular domain to detect both TrkB.FL and TrkB.T1, phospho-TrkB.FL at tyrosine 515 (p-TrkB.FL), phospho-ERK (p-ERK), ERK and Gapdh as controls. ( B ) TrkB.T1- /- neurons have increased BDNF signaling. Immunoblot analysis of E18.5 WT and TrkB.T1- /- primary hippocampal neurons cultured for 6 days in vitro before BDNF treatment (1 ng/ml for 5 min; black bar). Antibodies are as in ( A ) except for the β-III-tubulin antibody used as neuronal marker. ( C, D ) Immunoblot quantification analysis from ( B ) of p-TrkB.FL ( C ) and p-ERK ( D ) expressed respectively, as relative percentage of p-TrkB.FL over total TrkB.FL and phospho-ERK over total ERK. n = 3 ± SEM. * = p ≤ 0.05, ** = p ≤ 0.01, *** = p ≤ 0.001 (Student’s t-test).
Bdnf Treatment, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bdnf treatment/product/Alomone Labs
Average 93 stars, based on 1 article reviews
bdnf treatment - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


Western blot analysis of the BDNF ( A , B ), trkB ( C , D ), and the PSA-NCAM ( E , F ), in the prefrontal (prelimbic/infralimbic) cortex of the RHA and the RLA rats, either untreated controls (CTRL) or treated with neonatal handling (NH). The values represent the densitometric analysis of the BDNF/GAPDH ( B ), trkB/GAPDH ( D ), and the PSA-NCAM/GAPDH ( F ) band grey optical density (O.D.) ratios. The bars denote the mean ± S.E.M. of 9–10 rats, in each experimental group. ***: p < 0.001 (post hoc Duncan’s multiple range test).

Journal: Brain Sciences

Article Title: Neonatal Handling Positively Modulates Anxiety, Sensorimotor Gating, Working Memory, and Cortico-Hippocampal Neuroplastic Adaptations in Two Genetically Selected Rat Strains Differing in Emotional and Cognitive Traits

doi: 10.3390/brainsci15080776

Figure Lengend Snippet: Western blot analysis of the BDNF ( A , B ), trkB ( C , D ), and the PSA-NCAM ( E , F ), in the prefrontal (prelimbic/infralimbic) cortex of the RHA and the RLA rats, either untreated controls (CTRL) or treated with neonatal handling (NH). The values represent the densitometric analysis of the BDNF/GAPDH ( B ), trkB/GAPDH ( D ), and the PSA-NCAM/GAPDH ( F ) band grey optical density (O.D.) ratios. The bars denote the mean ± S.E.M. of 9–10 rats, in each experimental group. ***: p < 0.001 (post hoc Duncan’s multiple range test).

Article Snippet: Molecular weight (mw) standards (Precision Plus Protein Western C Standards, Cat# 161–0376, Bio-Rad, Hercules, CA, USA) and recombinant human BDNF protein (rhBDNF) (Cat# B-257, Alomone Labs, Jerusalem, Israel) were run in parallel.

Techniques: Western Blot

Western blot analysis of the BDNF ( A , B ), trkB ( C , D ), and the PSA-NCAM ( E , F ), in the anterior cingulate cortex of the RHA and the RLA rats, either untreated controls (CTRL) or treated with neonatal handling (NH). The values represent the densitometric analysis of the BDNF/GAPDH ( B ), trkB/GAPDH ( D ), and the PSA-NCAM/GAPDH ( F ) band grey optical density (O.D.) ratios. The bars denote the mean ± S.E.M. of 9–10 rats, in each experimental group. **: p < 0.01 (post hoc Duncan’s multiple range test).

Journal: Brain Sciences

Article Title: Neonatal Handling Positively Modulates Anxiety, Sensorimotor Gating, Working Memory, and Cortico-Hippocampal Neuroplastic Adaptations in Two Genetically Selected Rat Strains Differing in Emotional and Cognitive Traits

doi: 10.3390/brainsci15080776

Figure Lengend Snippet: Western blot analysis of the BDNF ( A , B ), trkB ( C , D ), and the PSA-NCAM ( E , F ), in the anterior cingulate cortex of the RHA and the RLA rats, either untreated controls (CTRL) or treated with neonatal handling (NH). The values represent the densitometric analysis of the BDNF/GAPDH ( B ), trkB/GAPDH ( D ), and the PSA-NCAM/GAPDH ( F ) band grey optical density (O.D.) ratios. The bars denote the mean ± S.E.M. of 9–10 rats, in each experimental group. **: p < 0.01 (post hoc Duncan’s multiple range test).

Article Snippet: Molecular weight (mw) standards (Precision Plus Protein Western C Standards, Cat# 161–0376, Bio-Rad, Hercules, CA, USA) and recombinant human BDNF protein (rhBDNF) (Cat# B-257, Alomone Labs, Jerusalem, Israel) were run in parallel.

Techniques: Western Blot

Western blot analysis of the BDNF ( A , B ), trkB ( C , D ), and the PSA-NCAM ( E , F ), in the ventral hippocampus of the RHA and the RLA rats, either untreated controls (CTRL) or treated with neonatal handling (NH). The values represent the densitometric analysis of the BDNF/GAPDH ( B ), trkB/GAPDH ( D ), and the PSA-NCAM/GAPDH ( F ) band grey optical density (O.D.) ratios. The bars denote the mean ± S.E.M. of 9–10 rats, in each experimental group. *: p < 0.05; **: p < 0.02 (post hoc Duncan’s multiple range test).

Journal: Brain Sciences

Article Title: Neonatal Handling Positively Modulates Anxiety, Sensorimotor Gating, Working Memory, and Cortico-Hippocampal Neuroplastic Adaptations in Two Genetically Selected Rat Strains Differing in Emotional and Cognitive Traits

doi: 10.3390/brainsci15080776

Figure Lengend Snippet: Western blot analysis of the BDNF ( A , B ), trkB ( C , D ), and the PSA-NCAM ( E , F ), in the ventral hippocampus of the RHA and the RLA rats, either untreated controls (CTRL) or treated with neonatal handling (NH). The values represent the densitometric analysis of the BDNF/GAPDH ( B ), trkB/GAPDH ( D ), and the PSA-NCAM/GAPDH ( F ) band grey optical density (O.D.) ratios. The bars denote the mean ± S.E.M. of 9–10 rats, in each experimental group. *: p < 0.05; **: p < 0.02 (post hoc Duncan’s multiple range test).

Article Snippet: Molecular weight (mw) standards (Precision Plus Protein Western C Standards, Cat# 161–0376, Bio-Rad, Hercules, CA, USA) and recombinant human BDNF protein (rhBDNF) (Cat# B-257, Alomone Labs, Jerusalem, Israel) were run in parallel.

Techniques: Western Blot

Western blot analysis of the BDNF ( A , B ), trkB ( C , D ), and the PSA-NCAM ( E , F ), in the dorsal hippocampus of the RHA and the RLA rats, either untreated controls (CTRL) or treated with neonatal handling (NH). The values represent the densitometric analysis of the BDNF/GAPDH ( B ), trkB/GAPDH ( D ), and the PSA-NCAM/GAPDH ( F ) band grey optical density (O.D.) ratios. The bars denote the mean ± S.E.M. of 9–10 rats, in each experimental group.

Journal: Brain Sciences

Article Title: Neonatal Handling Positively Modulates Anxiety, Sensorimotor Gating, Working Memory, and Cortico-Hippocampal Neuroplastic Adaptations in Two Genetically Selected Rat Strains Differing in Emotional and Cognitive Traits

doi: 10.3390/brainsci15080776

Figure Lengend Snippet: Western blot analysis of the BDNF ( A , B ), trkB ( C , D ), and the PSA-NCAM ( E , F ), in the dorsal hippocampus of the RHA and the RLA rats, either untreated controls (CTRL) or treated with neonatal handling (NH). The values represent the densitometric analysis of the BDNF/GAPDH ( B ), trkB/GAPDH ( D ), and the PSA-NCAM/GAPDH ( F ) band grey optical density (O.D.) ratios. The bars denote the mean ± S.E.M. of 9–10 rats, in each experimental group.

Article Snippet: Molecular weight (mw) standards (Precision Plus Protein Western C Standards, Cat# 161–0376, Bio-Rad, Hercules, CA, USA) and recombinant human BDNF protein (rhBDNF) (Cat# B-257, Alomone Labs, Jerusalem, Israel) were run in parallel.

Techniques: Western Blot

(A) DIV 7 compartmentalized mouse cortical neurons were retrograde labeled with Ctb555 (red) overnight. At DIV 8, the cell body compartment was treated with TrkB-Fc, and the AC was treated with DyLight 488-conjugated streptavidin alone (Control) or with biotinylated BDNF coupled to DyLight 488-conjugated streptavidin (f-BDNF, 150 ng/mL) for 6 hours in the absence (BDNF, green) or presence of 5 μM U-73122 (BDNF + U-173122) or 20 μM BAPTA, AM (BDNF + BAPTA). Then, the cells were fixed, mounted in Mowiol containing Hoechst (blue) and prepared for visualization. The circles in the BDNF panel indicate the smallest BDNF endosome considered for the analysis shown in B. Scale bar, 5 μm (B) Quantification of BDNF-positive vesicles in cell bodies of neurons containing Ctb555. Only vesicles larger than 20*10 -2 μm 2 as shown in the BDNF treatment group by the circles in panel A were considered for the analysis. Forty-five neurons from three independent compartmentalized cultures were considered. Statistical analysis was performed by one-way ANOVA followed by the Bonferroni correction for multiple comparisons. **** P<0.0001. (C) Left panels, representative images of DyLight 488-conjugated streptavidin (green) associated fluorescence. White lines are selecting the region of the microgroove label with Ctb555 (red) shown in the right panels. White arrows indicate DyLight 488-conjugated streptavidin positive vesicles (control) or f-BDNF positive vesicles in the lower panels. Right panels, Representative images of axons (labeled with Ctb555, red) in microgrooves of neurons treated as described in A. Scale bar, 5 μm. (D) Quantification of BDNF-positive vesicles in microgrooves of axons containing Ctb555. Forty-five microgrooves from three independent compartmentalized cultures were considered for the analysis. Statistical analysis was performed by one-way ANOVA followed by the Bonferroni correction for multiple comparisons. **** P<0.0001.

Journal: bioRxiv

Article Title: Axonal PLC-γ activity is required for BDNF long-distance signaling

doi: 10.1101/2023.11.10.566602

Figure Lengend Snippet: (A) DIV 7 compartmentalized mouse cortical neurons were retrograde labeled with Ctb555 (red) overnight. At DIV 8, the cell body compartment was treated with TrkB-Fc, and the AC was treated with DyLight 488-conjugated streptavidin alone (Control) or with biotinylated BDNF coupled to DyLight 488-conjugated streptavidin (f-BDNF, 150 ng/mL) for 6 hours in the absence (BDNF, green) or presence of 5 μM U-73122 (BDNF + U-173122) or 20 μM BAPTA, AM (BDNF + BAPTA). Then, the cells were fixed, mounted in Mowiol containing Hoechst (blue) and prepared for visualization. The circles in the BDNF panel indicate the smallest BDNF endosome considered for the analysis shown in B. Scale bar, 5 μm (B) Quantification of BDNF-positive vesicles in cell bodies of neurons containing Ctb555. Only vesicles larger than 20*10 -2 μm 2 as shown in the BDNF treatment group by the circles in panel A were considered for the analysis. Forty-five neurons from three independent compartmentalized cultures were considered. Statistical analysis was performed by one-way ANOVA followed by the Bonferroni correction for multiple comparisons. **** P<0.0001. (C) Left panels, representative images of DyLight 488-conjugated streptavidin (green) associated fluorescence. White lines are selecting the region of the microgroove label with Ctb555 (red) shown in the right panels. White arrows indicate DyLight 488-conjugated streptavidin positive vesicles (control) or f-BDNF positive vesicles in the lower panels. Right panels, Representative images of axons (labeled with Ctb555, red) in microgrooves of neurons treated as described in A. Scale bar, 5 μm. (D) Quantification of BDNF-positive vesicles in microgrooves of axons containing Ctb555. Forty-five microgrooves from three independent compartmentalized cultures were considered for the analysis. Statistical analysis was performed by one-way ANOVA followed by the Bonferroni correction for multiple comparisons. **** P<0.0001.

Article Snippet: To prepare fluorescent BDNF (f-BDNF), commercially available biotinylated BDNF (Alomone Labs, cat# B-250-B) was coupled to DyLight 488-conjugated streptavidin (Invitrogen, cat# 21832) by incubation at 37°C for 20 minutes; the reaction consisted of 6 µL of a 6 µM solution of DyLight 488-conjugated streptavidin and 2 µL of a 6 µM solution of biotinylated BDNF diluted in 72 µL of neurobasal medium supplemented with 0.1% BSA (molar range 1:1).

Techniques: Labeling, Control, Fluorescence

BDNF/TrkB signaling pathway modulates Munc18-1 phosphorylation under muscle contraction conditions. Representative Western blot bands and quantification show that both exogenous BDNF and 47/TrkB significantly decrease pMunc18-1 levels after stimulation resulting in contraction. Moreover, exogenous BDNF decreases Munc18-1 levels under these conditions. Data are mean percentage ± SEM, * p < 0.05 ( n = 5).

Journal: Frontiers in Molecular Neuroscience

Article Title: BDNF-TrkB Signaling Coupled to nPKCε and cPKCβI Modulate the Phosphorylation of the Exocytotic Protein Munc18-1 During Synaptic Activity at the Neuromuscular Junction

doi: 10.3389/fnmol.2018.00207

Figure Lengend Snippet: BDNF/TrkB signaling pathway modulates Munc18-1 phosphorylation under muscle contraction conditions. Representative Western blot bands and quantification show that both exogenous BDNF and 47/TrkB significantly decrease pMunc18-1 levels after stimulation resulting in contraction. Moreover, exogenous BDNF decreases Munc18-1 levels under these conditions. Data are mean percentage ± SEM, * p < 0.05 ( n = 5).

Article Snippet: For BDNF exogenous incubations we used h-BDNF (Alomone Labs; Cat# B-250) in a working solution of 10 mM.

Techniques: Western Blot

( A ) TrkB activation by BDNF is decreased by increased levels of TrkB.T1. HEK293 cells stably expressing TrkB.FL were transfected with increasing amounts of a TrkB.T1 expressing plasmid (0.3 µg, 0.5 µg and 1 µg) before BDNF treatment (5 ng/ml for 5 min). Immunoblots were probed with antibodies against TrkB extracellular domain to detect both TrkB.FL and TrkB.T1, phospho-TrkB.FL at tyrosine 515 (p-TrkB.FL), phospho-ERK (p-ERK), ERK and Gapdh as controls. ( B ) TrkB.T1- /- neurons have increased BDNF signaling. Immunoblot analysis of E18.5 WT and TrkB.T1- /- primary hippocampal neurons cultured for 6 days in vitro before BDNF treatment (1 ng/ml for 5 min; black bar). Antibodies are as in ( A ) except for the β-III-tubulin antibody used as neuronal marker. ( C, D ) Immunoblot quantification analysis from ( B ) of p-TrkB.FL ( C ) and p-ERK ( D ) expressed respectively, as relative percentage of p-TrkB.FL over total TrkB.FL and phospho-ERK over total ERK. n = 3 ± SEM. * = p ≤ 0.05, ** = p ≤ 0.01, *** = p ≤ 0.001 (Student’s t-test).

Journal: eLife

Article Title: Rbfox1 up-regulation impairs BDNF-dependent hippocampal LTP by dysregulating TrkB isoform expression levels

doi: 10.7554/eLife.49673

Figure Lengend Snippet: ( A ) TrkB activation by BDNF is decreased by increased levels of TrkB.T1. HEK293 cells stably expressing TrkB.FL were transfected with increasing amounts of a TrkB.T1 expressing plasmid (0.3 µg, 0.5 µg and 1 µg) before BDNF treatment (5 ng/ml for 5 min). Immunoblots were probed with antibodies against TrkB extracellular domain to detect both TrkB.FL and TrkB.T1, phospho-TrkB.FL at tyrosine 515 (p-TrkB.FL), phospho-ERK (p-ERK), ERK and Gapdh as controls. ( B ) TrkB.T1- /- neurons have increased BDNF signaling. Immunoblot analysis of E18.5 WT and TrkB.T1- /- primary hippocampal neurons cultured for 6 days in vitro before BDNF treatment (1 ng/ml for 5 min; black bar). Antibodies are as in ( A ) except for the β-III-tubulin antibody used as neuronal marker. ( C, D ) Immunoblot quantification analysis from ( B ) of p-TrkB.FL ( C ) and p-ERK ( D ) expressed respectively, as relative percentage of p-TrkB.FL over total TrkB.FL and phospho-ERK over total ERK. n = 3 ± SEM. * = p ≤ 0.05, ** = p ≤ 0.01, *** = p ≤ 0.001 (Student’s t-test).

Article Snippet: Primary neurons were starved in Neurobasal media without B27 supplement (Gibco) for 5 hr before BDNF treatment for 5 min (1 ng/ml; Alomone Labs, Cat# B-250).

Techniques: Activation Assay, Stable Transfection, Expressing, Transfection, Plasmid Preparation, Western Blot, Cell Culture, In Vitro, Marker

T1 receptor allele. ( A ) Averaged time-course of the field excitatory postsynaptic potential (fEPSP) slope in hippocampal slices from control (Ctrl = Nes Cre, n = 10), N-cre;Fox1( Nes-Cre;R26-Rbfox1 +/flox ; n = 10) and N-cre;Fox1;T1+/- ( Nes-Cre;R26-Rbfox1 +/flox ;TrkB.T1 +/- ; n = 13) mice after extracellular application of BDNF (20 ng/ml). Values are expressed as fEPSP percentage of the baseline values (average of 5 min before BDNF application, mean ± SEM). BDNF application (20 min) is indicated by the black horizontal bar. ( B ) Histogram showing mean ± SEM of the fEPSP slope average at 50 min after BDNF infusion; *** = p ≤ 0.001; ** = p ≤ 0.01; * = p ≤ 0.05 (Student’s t-test). ( C ) Representative recording traces of slices before (baseline = black line) and 50 min after BDNF application (red line). ( D ) Western blot analysis of hippocampus expression of TrkB, Rbfox1 and Gapdh of animals analyzed in ( A–C ).

Journal: eLife

Article Title: Rbfox1 up-regulation impairs BDNF-dependent hippocampal LTP by dysregulating TrkB isoform expression levels

doi: 10.7554/eLife.49673

Figure Lengend Snippet: T1 receptor allele. ( A ) Averaged time-course of the field excitatory postsynaptic potential (fEPSP) slope in hippocampal slices from control (Ctrl = Nes Cre, n = 10), N-cre;Fox1( Nes-Cre;R26-Rbfox1 +/flox ; n = 10) and N-cre;Fox1;T1+/- ( Nes-Cre;R26-Rbfox1 +/flox ;TrkB.T1 +/- ; n = 13) mice after extracellular application of BDNF (20 ng/ml). Values are expressed as fEPSP percentage of the baseline values (average of 5 min before BDNF application, mean ± SEM). BDNF application (20 min) is indicated by the black horizontal bar. ( B ) Histogram showing mean ± SEM of the fEPSP slope average at 50 min after BDNF infusion; *** = p ≤ 0.001; ** = p ≤ 0.01; * = p ≤ 0.05 (Student’s t-test). ( C ) Representative recording traces of slices before (baseline = black line) and 50 min after BDNF application (red line). ( D ) Western blot analysis of hippocampus expression of TrkB, Rbfox1 and Gapdh of animals analyzed in ( A–C ).

Article Snippet: Primary neurons were starved in Neurobasal media without B27 supplement (Gibco) for 5 hr before BDNF treatment for 5 min (1 ng/ml; Alomone Labs, Cat# B-250).

Techniques: Western Blot, Expressing

T1 heterozygous animals. ( A ) Averaged time-course of changes in field excitatory postsynaptic potential (fEPSP) slope after extracellular application of BDNF (20 ng/ml) in mouse hippocampal slices from control (Ctrl; Nes -cre, n = 10) and TrkB.T1 heterozygous animals (T1+/-; n = 8). Values are expressed as fEPSP percentage of baseline values (average of 5 min before BDNF application, mean ± SEM). BDNF application (20 min) is indicated by the black horizontal bar. ( B ) Histogram showing the average mean ± SEM of the fEPSP slope at 50 min after BDNF infusion (n.s.: Student’s t-test). ( C ) Western blot analysis of hippocampal expression of TrkB, Rbfox1 and Gapdh of animals as in ( A ).

Journal: eLife

Article Title: Rbfox1 up-regulation impairs BDNF-dependent hippocampal LTP by dysregulating TrkB isoform expression levels

doi: 10.7554/eLife.49673

Figure Lengend Snippet: T1 heterozygous animals. ( A ) Averaged time-course of changes in field excitatory postsynaptic potential (fEPSP) slope after extracellular application of BDNF (20 ng/ml) in mouse hippocampal slices from control (Ctrl; Nes -cre, n = 10) and TrkB.T1 heterozygous animals (T1+/-; n = 8). Values are expressed as fEPSP percentage of baseline values (average of 5 min before BDNF application, mean ± SEM). BDNF application (20 min) is indicated by the black horizontal bar. ( B ) Histogram showing the average mean ± SEM of the fEPSP slope at 50 min after BDNF infusion (n.s.: Student’s t-test). ( C ) Western blot analysis of hippocampal expression of TrkB, Rbfox1 and Gapdh of animals as in ( A ).

Article Snippet: Primary neurons were starved in Neurobasal media without B27 supplement (Gibco) for 5 hr before BDNF treatment for 5 min (1 ng/ml; Alomone Labs, Cat# B-250).

Techniques: Western Blot, Expressing